Ambrx Biopharma, Inc.
DelistedCIK 1990550fmd_0J25K94AW33K4DPJ4P3HEQ4BP5Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2022 to Sep 30, 2023, 2 periods
Latest quarter · Q3 FY2023
Millions- Total revenues
- 0
- Operating income
- (26)
- Net income
- (23)